ClinicalTrials.Veeva

Menu

Implementation of a Post-traumatic Stress Disorder PREvention Program Within the French ARmy (PREPAR)

D

Direction Centrale du Service de Santé des Armées

Status

Unknown

Conditions

Post Traumatic Stress Disorder

Treatments

Other: Primary prevention programm

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05094531
2020PBMD03

Details and patient eligibility

About

Post-Traumatic Stress Disorder (PTSD) is a mental health condition that's triggered by a terrifying event perceived as a life threatening - either experiencing it or witnessing it. Lifetime prevalence of PTSD in the European population is between 0.7% and 1.9%. According to the "dose-response" model, the individuals most exposed to traumatic events (TEs) are those who are most at risk of developing this disorder. This is why it is not surprising to observe a higher prevalence of this disorder in the military population, ranging from 10% to 18% or even 45%, depending on the studies.

In the 1980s, the practice of evidence-based preventive medicine (EBM-Evidence Based Medicine) was developed. It involves the conscientious, explicit, judicious and reasonable use of modern, best evidence in making decisions about the care of individual patients. EBM integrates clinical experience and patient values with the best available research information. Health condition prevention includes several levels of action: primary, secondary or tertiary, depending on the timing of the intervention in the course of the disease.

The aim of this project is to explore the efficiency of primary prevention actions in strengthening the resilience capacities of at-risk professionals, such as the military, in order to prevent the development of PTSD and to improve it prognosis.

The objectives of this project are (i) to design a primary prevention program for PTSD specific to the military population studied and compatible with the operational constraints of field soldiers, (ii) then, to implement / validate it within the operational staff of the Mountain Infantry Brigade (MIB).

Our approach is based on an integrative reading of the processes in the risk of developing PTSD. This biopsychosocial approach targets both the factors specific to the individual (on the physiological and psychological level) and the contextual and social factors relating to his professional environment.

Three dimensions are addressed: (i) biophysiology (by integrating the study of key biomarkers of the neurobiological response to stress, and by strengthening the flexibility of the autonomic nervous system), (ii) psychology (by facilitating and measuring the development of the flexibility of coping strategies to cope with stress as well as by evaluating the moderating role of the sense mission in the development of PTSD) and (iii) the social (by facilitating community strategies aimed at reducing stigmatization and facilitating the use of care for professionals in difficulty in the institutional context).

Enrollment

116 estimated patients

Sex

Male

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Social security affiliation
  • Combat unit soldier with certificate of military efficiency
  • With at least a 12-months employment contract within the MIB
  • Able to attend all the workshops
  • Not member of the Groupement Commando de Montagne

Exclusion criteria

  • Participant of the PREPAR Phase 1
  • Under chronic medication (daily treatment for at least a month)
  • Unwilling to participate
  • With a overseas deployment scheduled within the next 12 months
  • Adult persons subject to a legal protection measure

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

116 participants in 2 patient groups

Intervention group
Experimental group
Description:
Participants of this experimental group will have to attend the prevention program which is organised in eight 2-hour workshops, one every other week. Groups of 10-12 participants will be established prior to the first session of the program and will remain the same throughout the program.
Treatment:
Other: Primary prevention programm
No-intervention group
No Intervention group
Description:
Participants of the no-intervention group will not have to attend the prevention program.

Trial contacts and locations

1

Loading...

Central trial contact

Marion Trousselard, PhD, MD; Anaïs Duffaud, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems